Adare Pharma Solutions' Capabilities And Capacity Update March 2022: Small Molecule

Provided is an overview of Adare Pharma Solutions’ integrated end-to-end CDMO services—which range from pre-formulation and development through to manufacturing and packaging—with a special emphasis on the new and expanded capabilities acquired after their acquisition of Frontida Biopharm in December 2021.

To view the entire library of presentations from the Small Molecule Outsourced Pharma Capacity Update, click here